MedTrace Logo

Target Organ Damage and Polymorphisms Vav-2 and Vav-3 in Hypertensive Subjects

NCT02022618 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 454

Last updated 2016-09-23

No results posted yet for this study

Summary

Objectives: To analyze the influence on the presence of target organ damage renal, cardiac and vascular of peripheral and central blood pressure, retinal vessels caliber, oxidative stress and polymorphisms of genes VAV-2-3 in hypertensive subjects.

Methodology: A cross- sectional design we will performed . Population: 486 hypertensive patients. Target organ damage will be assessed by tests recommended in 2013 European guidelines of hypertension. Blood pressure office and ambulatory, retinal caliber vassels,oxidative stress and polymorphisms VAL -2-3 will be measurement.

Conditions

Sponsors & Collaborators

  • Fundacion para la Investigacion y Formacion en Ciencias de la Salud

    lead OTHER

Principal Investigators

  • Manuel A Gomez Marcos, MD · Fundacion Infosalud

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02022618 on ClinicalTrials.gov